The availability of powerful genome-wide association study technology, during the last five years, has shown that most of the 'new' MS susceptibility loci are immune-response genes. It is clear that there is much novelty in the field of MS immunology, which has served as an impetus to invest in new therapies. This book looks at MS immunology as the basis for the present and - even more - the future of treatments for this complex autoimmune condition.

This book looks at multiple sclerosis immunology as the basis for the present and-even more-the future of treatments for this complex autoimmune condition.